{
 "drug": "Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "07/27/2026",
 "dayN": 29,
 "cat": "Pulmonary/Allergy",
 "companies": [
  "GlaxoSmithKline"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "07/27/2026",
   "update_type": "New",
   "initial_posting_date": "07/27/2026",
   "package_ndc": "0173-0715-22",
   "generic_name": "Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered",
   "contact_info": "888-825-5249",
   "related_info": "The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026.  The 120 dose presentation of this product will still be available.",
   "openfda": {
    "application_number": [
     "NDA021254"
    ],
    "brand_name": [
     "ADVAIR HFA"
    ],
    "generic_name": [
     "FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"
    ],
    "manufacturer_name": [
     "GlaxoSmithKline LLC"
    ],
    "product_ndc": [
     "0173-0715",
     "0173-0716",
     "0173-0717"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RESPIRATORY (INHALATION)"
    ],
    "substance_name": [
     "FLUTICASONE PROPIONATE",
     "SALMETEROL XINAFOATE"
    ],
    "rxcui": [
     "896231",
     "896235",
     "896236",
     "896237",
     "896239",
     "896243",
     "896244",
     "896245",
     "896267",
     "896271",
     "896272",
     "896273"
    ],
    "spl_id": [
     "bea52e57-aa75-4dce-8cfb-a163bbc22be2"
    ],
    "spl_set_id": [
     "dfaca6f9-3277-47b2-319d-1377917cb54c"
    ],
    "package_ndc": [
     "0173-0715-20",
     "0173-0715-22",
     "0173-0716-20",
     "0173-0716-22",
     "0173-0717-20",
     "0173-0717-22"
    ],
    "unii": [
     "O2GMZ0LF5W",
     "6EW8Q962A5"
    ]
   },
   "update_date": "07/27/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy"
   ],
   "presentation": "Advair HFA, Aerosol, Metered, 45 ug; 21 ug (NDC 0173-0715-22)",
   "company_name": "GlaxoSmithKline",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "07/27/2026",
   "update_type": "New",
   "initial_posting_date": "07/27/2026",
   "package_ndc": "0173-0716-22",
   "generic_name": "Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered",
   "contact_info": "888-825-5249",
   "related_info": "The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026.  The 120 dose presentation of this product will still be available.",
   "openfda": {
    "application_number": [
     "NDA021254"
    ],
    "brand_name": [
     "ADVAIR HFA"
    ],
    "generic_name": [
     "FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"
    ],
    "manufacturer_name": [
     "GlaxoSmithKline LLC"
    ],
    "product_ndc": [
     "0173-0716",
     "0173-0715",
     "0173-0717"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RESPIRATORY (INHALATION)"
    ],
    "substance_name": [
     "FLUTICASONE PROPIONATE",
     "SALMETEROL XINAFOATE"
    ],
    "rxcui": [
     "896231",
     "896235",
     "896236",
     "896237",
     "896239",
     "896243",
     "896244",
     "896245",
     "896267",
     "896271",
     "896272",
     "896273"
    ],
    "spl_id": [
     "bea52e57-aa75-4dce-8cfb-a163bbc22be2"
    ],
    "spl_set_id": [
     "dfaca6f9-3277-47b2-319d-1377917cb54c"
    ],
    "package_ndc": [
     "0173-0715-20",
     "0173-0715-22",
     "0173-0716-20",
     "0173-0716-22",
     "0173-0717-20",
     "0173-0717-22"
    ],
    "unii": [
     "O2GMZ0LF5W",
     "6EW8Q962A5"
    ]
   },
   "update_date": "07/27/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy"
   ],
   "presentation": "Advair HFA, Aerosol, Metered, 115 ug; 21 ug (NDC 0173-0716-22)",
   "company_name": "GlaxoSmithKline",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "07/27/2026",
   "update_type": "New",
   "initial_posting_date": "07/27/2026",
   "package_ndc": "0173-0717-22",
   "generic_name": "Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered",
   "contact_info": "888-825-5249",
   "related_info": "The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026.  The 120 dose presentation of this product will still be available.",
   "openfda": {
    "application_number": [
     "NDA021254"
    ],
    "brand_name": [
     "ADVAIR HFA"
    ],
    "generic_name": [
     "FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"
    ],
    "manufacturer_name": [
     "GlaxoSmithKline LLC"
    ],
    "product_ndc": [
     "0173-0717",
     "0173-0715",
     "0173-0716"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RESPIRATORY (INHALATION)"
    ],
    "substance_name": [
     "FLUTICASONE PROPIONATE",
     "SALMETEROL XINAFOATE"
    ],
    "rxcui": [
     "896231",
     "896235",
     "896236",
     "896237",
     "896239",
     "896243",
     "896244",
     "896245",
     "896267",
     "896271",
     "896272",
     "896273"
    ],
    "spl_id": [
     "bea52e57-aa75-4dce-8cfb-a163bbc22be2"
    ],
    "spl_set_id": [
     "dfaca6f9-3277-47b2-319d-1377917cb54c"
    ],
    "package_ndc": [
     "0173-0715-20",
     "0173-0715-22",
     "0173-0716-20",
     "0173-0716-22",
     "0173-0717-20",
     "0173-0717-22"
    ],
    "unii": [
     "O2GMZ0LF5W",
     "6EW8Q962A5"
    ]
   },
   "update_date": "07/27/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy"
   ],
   "presentation": "Advair HFA, Aerosol, Metered, 230 ug; 21 ug (NDC 0173-0717-22)",
   "company_name": "GlaxoSmithKline",
   "status": "To Be Discontinued"
  }
 ]
}